PURPOSETo assess the relief of dentin hypersensitivity of the new toothpaste with stabilized stannous fluoride (SnF₂) versus a marketed standard fluoride toothpaste as a negative control and a marketed anhydrous SnF₂ toothpaste as a positive control.METHODSThis was a single-centered, randomized, controlled, double blind, clinical trial. 96 participants with hypersensitivity were enrolled in this 4-week clinical study. Electrical stimulation and evaporative air tests were performed to evaluate the desensitization efficacy. Clinical assessments were made at baseline, and after 3 days, 1 week, 2 weeks and 4 weeks of twice-daily brushing. Additionally, the influence of Sn² ⁺ species on desensitization was evaluated using bovine dentin specimens treated with toothpaste.RESULTSAll 96 enrolled participants were randomized. 96 participants completed all evaluations. Participants had an average age (SD) of 47.0 (10.5) years; 45% of participants were female. Both SnF₂ toothpastes showed superior desensitization efficacy compared to the negative control toothpaste, the conventional sodium monofluorophosphate (SMFP) toothpaste, after a week. The new stabilized SnF₂ toothpaste demonstrated improved electrical stimulation benefits compared to the negative control toothpaste, with increases of 15.1% after 3 days, 34.2% after 1 week, 66.3% after 2 weeks, and 111.6% after 4 weeks. Additionally, it showed relative verbal evaluation scale (VES) benefits of 14.2% after 3 days, 37.6% after 1 week, 28.9% after 2 weeks, and 37.4% after 4 weeks. The stabilized SnF₂ toothpaste exhibited desensitization properties comparable to those of a commercial anhydrous SnF₂ toothpaste, which typically produces undesirable side effects in the mouth. Toothpastes containing 0.454 % SnF₂ exhibited perfect occlusion of dentin tubules.CLINICAL SIGNIFICANCEThe stabilized 0.454% SnF₂ toothpaste exhibited significantly greater dentin hypersensitivity relief within only a week and comparable property to commercial anhydrous SnF₂ toothpaste.